A perspective current and past modes of inhalation therapy
Metadatos
Mostrar el registro completo del ítemAutor
Canto Mangana, José; Aguirre Schilder, Kelsey; Bretones Pedrinaci, José Ignacio; Márquez Blesa, Ana Rosa; Sánchez De Medina López-Huertas, Fermín; Martínez Augustín, María Olga; Daddaoua, AbdelaliEditorial
John Wiley & Sons
Fecha
2024-02-22Referencia bibliográfica
Canto Mangana, J., Schilder, K.A., Bretones-Pedrinaci, J.I., Blesa, A.R.M., de Medina, F.S., Martínez-Augustin, O. et al. (2024) A perspective current and past modes of inhalation therapy. Microbial Biotechnology, 17, e14419. Available from: https://doi.org/10.1111/1751-7915.14419
Resumen
Inhalation is the preferred route of delivery for anti-asthma
and chronic obstructive
pulmonary disease (COPD) drugs. The use of this route has demonstrated
efficacy in these and other conditions, it offers rapid onset of action,
and is associated with minimal systemic exposure, thereby reducing the risk
of adverse effects. Therefore, the current brief covers an interesting collection
of inhaler action modes, shedding light on their molecular mechanisms
and clinical applications for anti-asthma,
COPD and antibacterial inhalation
therapy. Hence, not only enriches our understanding of inhalation therapy
molecular intricacies but also provides a comprehensive overview of the
evolving landscape in clinical and antibacterial inhalation therapy. In doing so,
it underscores the pivotal role of microbiology and biotechnology in advancing
therapeutic approaches that harness the power of inhalation.